Moreover, numerous studies have suggested that tyrosinase may be involved in neuromelanin production and neuron damage characteristic of PD, highlighting tyrosinase inhibitors as potential therapeutic agents [11]. The gene discussed is TYR; the disease is Parkinson disease.